AU8388198A - Use of uridine to counter 5-fluorouracil toxicity - Google Patents

Use of uridine to counter 5-fluorouracil toxicity

Info

Publication number
AU8388198A
AU8388198A AU83881/98A AU8388198A AU8388198A AU 8388198 A AU8388198 A AU 8388198A AU 83881/98 A AU83881/98 A AU 83881/98A AU 8388198 A AU8388198 A AU 8388198A AU 8388198 A AU8388198 A AU 8388198A
Authority
AU
Australia
Prior art keywords
uridine
counter
fluorouracil toxicity
fluorouracil
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU83881/98A
Inventor
Simon P. Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
AbbVie Bioresearch Center Inc
Original Assignee
BASF SE
BASF Bioresearch Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE, BASF Bioresearch Corp filed Critical BASF SE
Publication of AU8388198A publication Critical patent/AU8388198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
AU83881/98A 1997-08-21 1998-07-13 Use of uridine to counter 5-fluorouracil toxicity Abandoned AU8388198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91576997A 1997-08-21 1997-08-21
US08915769 1997-08-21
PCT/US1998/014179 WO1999008686A1 (en) 1997-08-21 1998-07-13 Use of uridine to counter 5-fluorouracil toxicity

Publications (1)

Publication Number Publication Date
AU8388198A true AU8388198A (en) 1999-03-08

Family

ID=25436223

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83881/98A Abandoned AU8388198A (en) 1997-08-21 1998-07-13 Use of uridine to counter 5-fluorouracil toxicity

Country Status (4)

Country Link
AR (1) AR013424A1 (en)
AU (1) AU8388198A (en)
HR (1) HRP980436A2 (en)
WO (1) WO1999008686A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529064C2 (en) * 2005-01-03 2007-04-24 Selectica Pharmaceuticals Ab Topical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
JPH04503814A (en) * 1989-06-21 1992-07-09 ザ・キャソリック・ユニバーシティー・オブ・アメリカ Antimalarial composition and method of use
AU6081294A (en) * 1993-05-14 1994-12-12 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides

Also Published As

Publication number Publication date
WO1999008686A1 (en) 1999-02-25
AR013424A1 (en) 2000-12-27
HRP980436A2 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
IL126638A0 (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
AU7648698A (en) Heterocyclic derivatives and their use as antithrombotic agents
AU7698698A (en) Methods and compositions for targeting compounds to muscle
AU4125099A (en) Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
AU2055201A (en) N6 heterocyclic 5' modified adenosine derivatives
IL136895A0 (en) Novel pharmaceutical compositions of uridine triphosphate
AU6550394A (en) Novel pyrimidine nucleosides
AU6935498A (en) Novel phosphate compounds and their use as medicaments
AUPO557497A0 (en) Improvements to underpants
AU5400096A (en) Novel cytosine and cytidine derivatives
AU2517399A (en) Utilization of substituted sulfonamides as antiviral agents and novel substances
AU8990298A (en) Improvements in or relating to contrast agents
AU4817599A (en) Antiviral alkyl substituted purine derivatives and their preparation
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
AU8816198A (en) Improvements in or relating to contrast agents
AU8388198A (en) Use of uridine to counter 5-fluorouracil toxicity
AUPO731697A0 (en) Improvements relating to combined steel-aluminium structures
AU6108499A (en) Pyrrolopyrrolone derivatives as antiviral agents
AU4347596A (en) Thienoxazinone derivatives useful as antiviral agents
AU3459697A (en) Novel pyrimidine compounds and drug compositions
GB2326329B (en) Improvements relating to shelving units
AU6141294A (en) Pyrimidine derivatives useful as pesticides
AU7031798A (en) Use of pivagabin to prepare pharmaceutical compositions
AU7343398A (en) Diphenylacetic acid derivatives and their use as antiviral agents
AU7772698A (en) Use of indolamines as antithrombotic medicine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase